Careers  |  Sign In  |  Register

Latest in Endocrinology

Reuters Health • The Doctor's Channel Daily Newscast

Thiazolidinediones up risk of fractures in older women

NEW YORK (Reuters Health) - Thiazolidinediones (TZDs) are linked to an increased risk for extremity fractures in women over age 65, findings from a large retrospective cohort study indicate. Mainly used in diabetics, TZDs are agonists of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), a...

Reuters Health • The Doctor's Channel Daily Newscast

ACE inhibitors, ARBs beat calcium blockers in cutting atrial fibrillation risk

NEW YORK (Reuters Health) – When it comes to preventing atrial fibrillation, not all antihypertensive agents are created equal.  New research suggests that angiotensin-converting enzyme (ACE) inhibitors, angiotensin II-receptor blockers (ARBs), and beta-blockers are all superior to calcium channel...

Reuters Health • The Doctor's Channel Daily Newscast

Diazoxide improves glycemic control in type 1 diabetes

NEW YORK (Reuters Health) - Daily treatment with diazoxide prompts a decrease in HbA1c in patients with newly diagnosed type 1 diabetes, Norwegian researchers report in the December 22nd online issue of Diabetes Care. "Our results demonstrate a safe and beneficial effect of intervention with...